AC
ABBV icon

Attessa Capital’s AbbVie ABBV Stock Holding History

Attessa Capital’s Portfolio ABBV Stock Details ABBV Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$865K Buy
3,438
+924
+37% +$199K 0.39% 20
2026
Q1 		$547K Sell
2,514
-38
-1% -$8.43K 0.3% 23
2025
Q4 		$583K Hold
2,552
– – 0.32% 20
2025
Q3 		$591K Hold
2,552
– – 0.35% 20
2025
Q2 		$474K Hold
2,552
– – 0.3% 22
2025
Q1 		$535K Sell
2,552
-128
-5% -$24.9K 0.35% 21
2024
Q4 		$476K Buy
+2,680
New +$493K 0.32% 25

Other funds holding ABBV

Sumitomo Mitsui Trust Group
Sumitomo Mitsui Trust Group Minato-Ku, Tokyo, Japan $175B AUM 40.63% 1-Year Est. Return
Robeco Institutional Asset Management
Robeco Institutional Asset Management Rotterdam, Netherlands $81.4B AUM 40.71% 1-Year Est. Return
Swedbank
Swedbank Stockholm, Sweden $116B AUM 46.87% 1-Year Est. Return
Truist Financial
Truist Financial Charlotte, North Carolina $83.7B AUM 27.22% 1-Year Est. Return
Assenagon Asset Management
Assenagon Asset Management Senningerberg, Luxembourg $80.2B AUM 50.57% 1-Year Est. Return
Aberdeen Group
Aberdeen Group Edinburgh, United Kingdom $71.2B AUM 41.74% 1-Year Est. Return
New York State Common Retirement Fund
New York State Common Retirement Fund Albany, New York $79.3B AUM 43.63% 1-Year Est. Return
ECSS
Eurizon Capital SGR SpA Milan $37.3B AUM
ATO
Alecta Tjanstepension Omsesidigt Stockholm, Sweden $23.8B AUM 34.25% 1-Year Est. Return
New York State Teachers Retirement System (NYSTRS)
New York State Teachers Retirement System (NYSTRS) Albany, New York $54.2B AUM 43.77% 1-Year Est. Return

Attessa Capital's ABBV Position: Q2 2026 in Review

Attessa Capital increased its AbbVie (ABBV) stake by 37% in Q2 2026, buying an estimated $199K and bringing the position to 3,438 shares worth $865K. The position accounts for 0.39% of the portfolio, ranked #20.

Attessa Capital first reported a position in ABBV in Q4 2024 and has held it in 7 quarters since. 2,121 funds tracked by Wall St. Rank hold ABBV as of Q2 2026.

  • Attessa Capital held 3,438 shares of AbbVie worth $865K as of Q2 2026.
  • Attessa Capital bought 924 AbbVie shares in Q2 2026, an estimated $199K.
  • AbbVie made up 0.39% of Attessa Capital's portfolio in Q2 2026, its #20 holding.
  • Attessa Capital first reported a position in AbbVie in Q4 2024 and has held it in 7 quarters since.
  • 2,121 funds tracked by Wall St. Rank held AbbVie as of Q2 2026.

Based on Attessa Capital's 13F filing for Q2 2026, filed 8 Jul 2026.